MENU
ABOS
AS OF
Feb 3 closing price
Price
$2.57
Change
+$0.32 (+14.22%)
Capitalization
155.98M
54 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ABOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acumen Pharmaceuticals (ABOS) Ownership - Who owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
155.98M
P/E Ratio
N/A
Total Cash
126.61M
Projected Growth
N/A
Total Debt
30.84M
Revenue
N/A
Risk (Beta)
3.28
Dividend Yield
N/A
Total Cash/Share
2.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ABOS
Capitalization
156M
P/E Ratio
N/A
Risk (Beta)
3.28
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
2.09
Total Debt
30.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
93.2M
P/B Ratio
1.67
Cash Flow
N/A
Earnings
-2.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
6.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-128.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-65.18
Shares Held By Institutions
74.2M
Shares Outstanding - Current
60.6M
Total Liabilities
49M
Total Volume MTD
N/A
Value
-1
Gain YTD
21.801
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ABOS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABOS showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ABOS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com